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Opioid users regularly consume other drugs such as alcohol (ethanol). Acute administration 
of ethanol can rapidly reverse tolerance to morphine-induced respiratory depression. 
However, alcohol consumption by opioid users is likely to occur over prolonged time 
periods. We have therefore sought to determine the effect of prolonged alcohol consumption 
on the development of tolerance to opioid respiratory depression.  
Methods 
Mice were fed control or ethanol (5%) liquid diet for 16 days. On days 9-16 morphine 
tolerance was induced by administration of 3 priming injections of morphine followed by 
subcutaneous implantation of a morphine-filled osmotic mini-pump. Control mice received 
saline. Respiration was measured by plethysmography and the effect of an acute morphine 
challenge dose was measured on day 16 to assess the development of morphine tolerance.  
Results 
Prolonged ethanol consumption for 14 days did not alter the respiratory depressant effect of 
an acute dose of morphine. Control mice treated with prolonged morphine developed 
tolerance to acute morphine respiratory depression whereas ethanol diet fed mice treated with 
prolonged morphine showed significant respiratory depression during morphine-pump 
treatment and remained sensitive to the respiratory depressant effect of the acute challenge 
dose of morphine. The ethanol consumption did not alter blood or brain levels of morphine, 
whilst conversely prolonged morphine treatment did not alter blood levels of ethanol.    
Conclusions 
Prolonged ethanol consumption prevents the development and maintenance of tolerance to 
the respiratory depressant effect of morphine. These data suggest that ethanol inhibition of 





Heroin users are notorious poly drug users and often take other drugs such as cocaine, alcohol 
(ethanol), benzodiazepines, amphetamine and gabapentinoids in addition to heroin or other 
opioids (Darke and Hall, 2003, Borriello et al., 2014, Preston et al., 2016, Lyndon et al., 
2017, Wang et al., 2017, Moses et al., 2018, Palamar et al., 2018). An important question is 
how use of these other drugs might alter the risk of opioid overdose.  Death in acute opioid 
overdose results primarily from respiratory depression (Pattinson, 2008, Montandon and 
Slutsky, 2019), although in some instances inhalation of vomit may also be a factor. With a 
depressant such as ethanol it is generally assumed that its effect will simply be additive with 
that of an opioid, increasing the level of respiratory depression thus making overdose more 
likely. However, the levels of ethanol found in heroin overdose deaths are rarely high 
(Darke and Hall, 2003, Hickman et al., 2007, Shah et al., 2008, Green et al., 2011, 
Fugelstad et al., 2014) which may indicate some other form of interaction other than 
simple additivity (Hickman et al., 2008). 
 
We have previously reported that in mice acute, low doses of ethanol rapidly reverse 
tolerance to the respiratory depressant and analgesic effects of morphine and oxycodone 
(Hull et al., 2013, Hill et al., 2016, Jacob et al., 2017, Hill et al., 2018) but do not reverse 
tolerance induced by methadone (Hill et al., 2016). Reversal of morphine tolerance by a low 
concentration of ethanol (20 mM) can also be observed at the single neuron level in vitro 
(Llorente et al., 2013, Jacob et al., 2018) indicating that the effect is at the level of cells 
-opioid receptors to reverse receptor desensitization, rather than an action to 
alter drug disposition in the brain.  
 
Although acute ethanol administration reversed morphine tolerance in animal studies, 
heroin users are likely to drink alcohol over prolonged periods of time and this may produce a 
different interaction given that prolonged exposure to ethanol is known to exert a plethora of 
effects on enzyme and regulatory protein activity or expression (Elves et al., 1984, You et al., 
2002, Sivapiriya et al., 2006) as well as receptor regulation (Fischer et al., 2003, Gustot et al., 
2006, Nagy, 2008). Therefore, in the present study we have examined the effect of prolonged 
ethanol consumption on the acute respiratory depressant response to morphine and on the 
subsequent induction and maintenance of tolerance to morphine. To do this we fed mice on a 
diet containing ethanol (Bertola et al., 2013) prior to exposing them to morphine and 
observed how the exposure to ethanol affected the acute response morphine and the level of 
tolerance that developed to morphine-induced respiratory depression. Prolonged exposure to 
ethanol did not alter the respiratory depressant effect of an acute dose of morphine but was 
found to prevent the development of tolerance to morphine respiratory depression. 
  
2 METHODS AND MATERIALS 
2.1 Animals 
Male CD-1 mice (Charles River, UK) weighing approximately 30 g (at the beginning 
of the experiment) were maintained at 22 °C on a reversed 12 h dark-light cycle with food 
and water available ad libitum prior to experimental diet administration. All experiments 
were performed in the dark (active) phase. Mice were randomly ascribed to treatment groups 
with the experimenter blinded to the drug treatment. All procedures were performed in 
accordance with the UK Animals (Scientific Procedures) Act 1986, the European 
Communities Council Directive (2010/63/EU) and all protocols were approved by the 
University of Bristol’s Animal Welfare and Ethics Review Board. 
 
2.2 Administration of ethanol diet 
Mice were housed in groups of 4. Each cage had a single ball bearing feeder filled 
with ethanol (5%) or control liquid diet. Diets were made up fresh each morning and swapped 
with the previous day’s feed before the dark (active) cycle began. Diet consumption was 
measured every day and animal weight was measured every third day. Lieber Decarli ’82 
ethanol diet was procured from (Bio-Serv, USA) and made up according to previously 
published guidelines (Bertola et al., 2013). 
  
Each cage was provided with 150 ml of control or ethanol liquid diet each day. Control diet 
was made by combining 114 g of control diet mix with water up to a total volume of 500 ml. 
Ethanol diet was made by combining 66.5 g of ethanol diet mix, 10.2 g of maltose dextrin, 
and 26.3 ml of ethanol. This was made up to a total volume of 500ml with water. Maltose 
dextrin was used to calorie balance the ethanol diet with the control diet. Diets were 
thoroughly mixed to ensure all ingredients were fully dissolved and to prevent blockages of 
the feeding bottles. Additional access to water is not required when mice are fed on liquid 
diets and thus was not provided (Bertola et al., 2013). Diet consumption was measured as 
weight consumed each day per cage and divided by the number of mice per cage to calculate 
average diet consumption per mouse per day. 
 
2.3 Measurement of respiration 
Respiration was measured in freely moving mice using plethysmography chambers (EMKA 
Technologies, France) supplied with a 5% CO2 in air mixture (BOC Gas Supplies, UK) as 
described previously (Hill et al., 2016). Rate and depth of respiration were recorded and 
converted to minute volume. In some experiments the change in minute volume following 
acute drug administration for each mouse was calculated as the percentage of the pre-drug 
baseline. Presenting data as percentage change from the pre‐ drug levels has been performed 
to control for variation between treatment groups that may have different baseline levels of 
respiration.  
 
2.4 Prolonged morphine treatment 
After 8 days of exposure to control or ethanol liquid diet prolonged morphine 
treatment was initiated by first administering three priming injections of morphine (100 
mg/kg i.p.) at 12 h intervals followed by subcutaneous implantation on the dorsal flank of an 
osmotic mini-pump (ALZET®) containing 56.25 mg/ml morphine (to deliver 45 mg/kg/day) 
for a further 6 days. Control mice received saline injections and implantation of an osmotic 
mini-pump containing saline. Implantation of osmotic mini-pumps was done under brief (<5 
min) isoflurane general anesthesia.  
 
2.5. Assessment of opioid tolerance 
To assess the level of tolerance induced by prolonged morphine treatment, mice were 
injected with an acute challenge dose of morphine (10 mg/kg i.p.) on the final day of the 
experiment and respiration monitored for 30 min. The degree of respiratory depression 
observed in prolonged morphine-treated mice was compared to that observed in saline-treated 
mice which had also been administered an acute challenge dose of morphine (10 mg/kg i.p.). 
 
2.6. Measurement of ethanol and morphine levels  
At the end of the experiment (day 16), mice were exsanguinated following death by 
escalating CO2 administration. Blood was then collected from the descending abdominal 
aorta. Syringes used for the collection of blood samples were pre-filled with 0.1ml of heparin 
(200 units/ml). 100 μl of each plasma supernatant was mixed thoroughly with 500 μl 
acetonitrile containing 200 ng/ml of deuterated morphine as internal standard and centrifuged 
at 13 000 r.p.m. for 10 min at room temperature. Additional 100 μl volumes of each plasma 
supernatant was mixed thoroughly with 500 μl of pure acetonitrile for analysis of ethanol 
levels. 300 μl samples of the supernatant were evaporated to dryness using a speed vac. 
 
Immediately after collection of blood samples, the brains of the mice were removed 
and flash frozen in liquid nitrogen.  Brains were homogenized in phosphate buffer solution 
added at a ratio of 2 ml per gram of brain matter. 100 μl of aliquots of brain homogenate 
samples were mixed thoroughly with 500 μl acetonitrile containing 200 ng/ml of deuterated 
morphine as internal standard and extracted as described for plasma samples. 
 
For morphine determination plasma and brain samples were analyzed as follows. 
Samples were reconstituted in acetonitrile/H2O (20/80) and analyzed by liquid 
chromatography (Ultimate 3000 LC system, Dionex, USA)/tandem mass spectrometry (Q 
Exactive Orbitrap, Thermo Scientific, USA). Samples were analyzed in positive ion mode for 
morphine, hydromorphone, and morphine-3-glucuronide (M-3-G), the major metabolite of 
morphine in mice (Kuo et al., 1991). The quantification range for morphine was between 2.0 
and 20 000 ng/ml. Hydromorphone was not found in any of the samples.  
For ethanol determination μl 
acetonitrile before being dried by speed-vac. Samples were reconstituted in acetonitrile for 
analysis. Ethanol analysis was then performed using gas chromatography-mass spectrometry 
(GCMS) and was carried out on a Thermo Finnigan Trace gas chromatograph with a Thermo 
Finnigan Voyager GCMS. 
 
2.7 Experimental Design & Data Analysis. 
Group size was determined by power analysis (G*Power version 3.1.9.2) using 
previously obtained data (Hill et al., 2016). This indicated a group size of n=7 as being 
adequate to determine statistical difference between saline and morphine pump treated mice. 
A single group of mice (control diet fed, saline treated mice) are presented as n=6 due to a 
single fatality shortly after the experiment commenced. Also, blood/brain sampling 
difficulties sometimes provided inadequate sampling for one or both analyzes of morphine 
and ethanol levels, resulting in only n=6 for these assays. However post-hoc power analyzes 
confirmed that this remained sufficiently powered.  
 
Area under the curve (AUC) was determined using a 100% baseline as described 
previously (Hill et al., 2016). Overall changes from a single factor were analyzed using a 
One-way ANOVA with Bonferroni’s post-test. Interaction between prolonged drug treatment 
and challenge drug was analyzed using a Two-way ANOVA in a two-by-two factorial. 
Changes in groups over time with repeat measurements were analyzed using a Two-way 
repeated measures ANOVA with Bonferroni’s post-test to analyze drug effect over time. 
P values <0.05 were considered statistically significant. Student’s T-tests were used to 
compare single factor changes. Paired T-tests were used to compare within group changes of 
a single factor. All T-tests were two-tailed. GraphPad Prism 7 was used for all statistical 
analyzes. All data are displayed as mean ± standard error of the mean. 
 
2.8 Drugs. 
Morphine hydrochloride (Macfarlane Smith) was dissolved in sterile saline and 
administered i.p. for acute injections or dissolved in distilled water for prolonged 
administration using implanted osmotic mini-pumps. Distilled water was used in the mini-
pumps due to the lower solubility of morphine in saline. Heparin (Sigma Aldrich UK) was 
diluted in distilled water to 200 units/ml. 
3. RESULTS 
3.1. Prolonged ethanol intake and prolonged morphine treatment did not affect diet 
consumption or body weight 
Over the first 8 days of the experiment both control and ethanol fed mice consumed 
equivalent amounts of the liquid diets (Fig. 1A). There was also no difference in diet 
consumption in either the control or ethanol fed mice over days 9 – 16 when the mice were 
treated with saline or morphine (Fig. 1B). However, comparison of morphine treated mice on 
control diet with those on ethanol diet revealed that the consumption of diet was higher in 
control than in ethanol diet fed mice (Fig. 1B). Only mice fed on the control diet and treated 
with saline gained body weight over the 16 days of the experiment; in all other 
groups/treatments there was no significant change in body weight (Fig. 1C). 
 
3.2. Lack of morphine tolerance in mice fed on ethanol liquid diet. 
Following 8 days of control or ethanol diet consumption, respiration was monitored on the 
morning of day 9 just prior to initiating prolonged morphine treatment (Fig. 2A). There was 
no difference in minute volume between groups fed on control diet and those fed on ethanol 
diet. Mice continued to be fed on their respective diets and treated for a further 8 days with 
either saline or morphine. Respiration was measured on days 11 to 16 (i.e. following osmotic 
mini-pump implantation). Mice fed on control diet that then received prolonged morphine 
treatment did not show respiratory depression compared to mice also fed on control diet but 
treated with saline (Fig. 2B). This indicates that the 3 initial doses of morphine (100 mg/kg 
i.p.) administered on days 9 and 10 had induced tolerance to morphine depression of 
respiration such that no respiratory depression in response to morphine released from the 
osmotic mini-pumps was observed on days 11 to 16. In contrast, in mice that had been fed the 
ethanol diet, respiration was depressed on days 11 to 16 in the prolonged morphine treated 
mice but not in the saline treated mice (Fig. 2C). This suggests that prior ethanol exposure 
either prevents the development of tolerance to morphine or in some other way enhances the 
effect of morphine thus revealing the respiratory depressant effect of morphine released from 
the osmotic mini-pumps. 
 
On day 16, all groups of mice received an acute challenge dose of morphine (10 mg/kg i.p.) 
to determine their sensitivity to morphine depression of respiration. In control and ethanol 
diet fed mice treated with saline, respiration was depressed by the morphine challenge (Fig. 
3A, B and F). The time course and extent of the respiratory depression by morphine were 
similar for both treatments (40 – 50% depression after 15 – 20 minutes following drug 
injection). Thus, the consumption of the ethanol diet for 16 days did not enhance the 
respiratory depressant effects of the acute dose of morphine.  
 
In control diet fed mice that received prolonged morphine treatment the challenge dose of 
morphine on day 16 did not depress respiration (Fig. 3C, D and F). This demonstrates that the 
prolonged morphine treated mice were tolerant to the respiratory depressant effects of 
morphine. In mice that had been fed on the ethanol liquid diet and received prolonged 
morphine treatment the baseline respiration levels before the morphine challenge were lower 
than in mice fed the control diet (Fig. 3C and E). When these mice received the challenge 
dose of morphine on day 16 respiration was further depressed. These data indicate that 
ethanol diet fed mice did not develop tolerance during the prolonged morphine treatment and 
remained fully sensitive to the respiratory depressant effect of the acute morphine challenge. 
 
3.3. Ethanol diet did not alter brain or plasma levels of morphine. 
At the end of the morphine challenge experiments (see Fig. 3) mice were sacrificed and blood 
samples and brains taken for analysis of morphine and ethanol levels. The plasma ethanol 
levels achieved in ethanol diet fed animals of 208 ± 24 mg/dl (n = 6; Fig 4C) were similar to 
that reported by Bertola et al. (2013) using the same protocol. Following prolonged morphine 
treatment the plasma concentration of morphine was 100 ± 12 ng/ml (n = 6; Fig 4A) which is 
approximately 300 nM. There was no significant difference in either the brain or plasma 
levels of morphine in mice fed control or ethanol diet followed by prolonged morphine 
treatment (Fig 4A & B) indicating that ethanol intake had no effect on the distribution and 
metabolism of morphine. The plasma ethanol concentrations were the same in saline treated 
and prolonged morphine treated mice (Fig 4C). Hence, the enhanced response to the acute 
morphine challenge observed in prolonged morphine treated, ethanol fed mice (Fig 3) did not 
result from higher morphine or ethanol blood/brain levels.  
4 DISCUSSION 
 
In the present investigation we observed that prolonged ethanol treatment did not alter the 
acute respiratory depressant effect of morphine in mice. Morphine depresses respiration by 
activating of (Matthes et 
al., 1996, Romberg et al., 2003).  There have been reports that prolonged ethanol treatment 
-opioid receptor from G protein activation (Chen and Lawrence, 2000, 
Sim-Selley et al., 2002, Saland et al., 2004). However, uncoupling was seen in only some 
brain regions and not in others and therefore does not seem to be a ubiquitous, consistent 
response to ethanol treatment across the brain. He and Whistler (2011) reported that 
prolonged administration of high, binge doses of ethanol to rats reduced the antinociceptive 
response to acute morphine administration but with the ethanol treatment we used we did not 
observe any reduction in the respiratory depressant effect of morphine.  
 
Importantly, we observed that prolonged ethanol treatment did prevent the development of 
tolerance to morphine-induced respiratory depression. This inhibition of tolerance 
development extends our previous work in which we demonstrated that acute administration 
of a relatively low dose of ethanol reversed tolerance to morphine-induced respiratory 
depression (Hill et al., 2016) and antinociception (Hull et al., 2013). Furthermore, we have 
previously reported that a mildly intoxicating concentration of ethanol in humans (20 mM) 
reversed morphine-induced cellular tolerance in brain neurons (Llorente et al., 2013). If a 
similar phenomenon is observed in humans then ethanol reversal of tolerance would have two 
important consequences. First, consumption of alcohol by heroin users would result in a 
lower level of opioid tolerance, increasing the respiratory depressant response to heroin 
injection – heroin is rapidly converted to 6-monoacetylymorphine (6MAM) and then to 
morphine – and so increasing the likelihood of overdose and death. Second, between heroin 
injections users begin to experience symptoms of withdrawal increasing the drive to retake 
the drug. A reduced level of tolerance induced by alcohol consumption would enable low, 
residual levels of morphine in the body to  which might help to 
stave off the experience of withdrawal.  
 
-opioid receptor desensitizes, and this desensitization 
contributes to the level of tolerance (Williams et al., 2013). The mechanisms of -opioid 
receptor desensitization have been shown to be agonist-specific (Kelly et al., 2008), with 
good evidence to suggest that protein kinase C (PKC) mediates desensitization 
and tolerance induced by morphine, a relatively low efficacy agonist at -opioid receptor 
whereas G protein-coupled receptor kinases (GRKs) and arrestin binding mediates 
desensitization  (Williams et al., 
2013).  In our studies on tolerance to opioid-induced respiratory depression PKC inhibition 
reversed tolerance induced by prolonged morphine and oxycodone treatments but not 
tolerance induced by the high efficacy agonist methadone (Withey et al., 2017). One 
possibility is that ethanol may in some way block the PKC mechanism known to underlie 
tolerance to morphine Direct inhibition of 
conventional PKC isoforms by ethanol has been difficult to demonstrate, with only modest 
inhibition observed at high ethanol concentrations (see Llorente et al., 2013 for discussion). It 
is also possible that ethanol does not directly inhibit PKC activity but prevents PKC 
translocation to the receptors on the plasma membrane or that acetaldehyde rather than 
ethanol inhibits PKC (Domenicotti et al., 1998). 
 
At post mortem (autopsy) the presence of alcohol is more frequently detected in heroin-
related deaths than in those involving methadone (Bryant et al., 2004, Shah et al., 2005). This 
might relate to the ability of ethanol to reverse morphine but not methadone tolerance. In 
those deaths in which ethanol and methadone were found to be present at post mortem 
additivity of effect to depress respiration at high drug levels, rather than reversal of tolerance, 
is more likely to be the cause of death. 
 
We have previously reported that in mice, tolerance to respiratory depression induced by 
prolonged methadone treatment is not reversed by ethanol or PKC inhibitors (Hill et al., 
2016; Withey et al., 2017). 
opioid receptor (McPherson et al., 2010). If ethanol only reverses PKC-dependent tolerance, 
then consumption of alcohol would not reduce tolerance to the respiratory depressant effects 
of methadone.  
 
4.1 CONCLUSION 
Our study highlights the danger of poly drug abuse by heroin users and expands upon our 
previous work on ethanol reversal of tolerance to morphine respiratory depression. Here we 
clearly demonstrate that prior, prolonged exposure to ethanol prevents the development of 
tolerance to morphine respiratory depression. Thus in humans alcohol consumption will 
increase the likelihood of fatal overdose occurring with doses of heroin or morphine that 
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Figure 1. Consumption of liquid diets and mouse body weight.  
(A) Consumption of control or ethanol liquid diet per day (Days 1-8) by mice prior to 
treatment with saline or morphine. No significant difference in diet consumption was found 
between groups. (B) Consumption of liquid diet per day (Days 9-16) by mice during 
prolonged treatment with saline or morphine. Morphine treated, ethanol diet fed mice did not 
consume less ethanol diet than saline treated, ethanol diet fed mice, but did consume less than 
morphine treated, control diet fed mice. (C) Weight of mice on day 0 and day 16 on liquid 
diets. Only mice on the control liquid diet that received saline treatment for the last 8 days 
gained weight significantly. No other group of mice significantly lost or gained weight over 
the experimental period. In (A) and (B) mice were compared by One-way ANOVA with 
Bonferroni’s comparison. In C beginning and end weights were compared by a two-tailed 
paired Student’s T-test. * indicates p<0.05; N=7 for all groups except for control diet fed 
saline treatment mice where n=6.  
 
 
Figure 2. Effect of ethanol liquid diet on the development of tolerance to morphine 
depression of respiration.  
(A) Mice from all 4 groups did not have significantly different baseline respiration, measured 
as minute volume prior to saline or morphine treatment. The same data are reproduced as 
‘Day 9’ data points in (B) and (C). (B) Prolonged morphine treatment beginning on day 9 did 
not depress respiration in mice fed control liquid diet. (C) Prolonged morphine treatment 
beginning on day 9 did result in depression of respiration in mice fed the ethanol liquid diet. 
All mice were on their respective diets for 8 days prior to the saline and morphine treatments. 
Respiration was measured as minute volume. * indicates p<0.05. Groups compared by Two-
way ANOVA with Bonferroni’s comparison. N=7 for all groups except for control diet fed 
saline treatment mice where n=6.  
 
 
Figure 3. Effect of ethanol liquid diet on the expression of morphine tolerance.  
In (A) and (C), data are presented as minute volume (MV) whereas in (B) and (D), the data 
have been transformed such that the level of respiratory depression seen following morphine 
challenge is expressed as a percentage change in the pre-challenge MV baseline, calculated 
for each mouse individually before mean data were plotted. In (F) the data in (B) and (D) 
have been recalculated and plotted as the area under the curve (AUC). The AUC was 
calculated for each individual mouse (data points shown) before the mean AUC has been 
calculated (open histograms). In (A) and (B) acute morphine challenge (10 mg/kg i.p.) 
depressed respiration in mice fed the ethanol or control liquid diet and treated with saline for 
the last 8 days. In (C) and (D) morphine challenge did not cause a decrease in MV in mice 
fed control liquid diet and pre-treated with morphine for the last 8 days, but did cause a 
decrease in MV in mice morphine pre-treated mice fed ethanol liquid diet. In (E) baseline 
respiration prior to acute morphine treatment is shown (calculated from time 10-20 min in 
(A) and (C)). Only ethanol diet fed and morphine treated mice had significantly reduced 
baseline respiration. In (E) and (F) groups were compared by Two-way ANOVA with 
Bonferroni’s comparison. In C * indicates comparison to control diet fed mice prior to 
morphine challenge. * Indicates p<0.05; N=7 for all groups except for control diet fed, saline 
treatment mice, where n=6.  
 
Figure 4. Ethanol and morphine levels following prolonged ethanol liquid diet. 
 Plasma (A) and brain (B) levels of morphine in mice treated with morphine for the last 8 
days. There was no significant difference in plasma or brain levels of morphine in mice fed 
control or ethanol liquid diet. (C) Plasma ethanol levels in mice fed ethanol liquid diet for 16 
days. There was no significant difference in plasma ethanol levels between ethanol liquid diet 
fed mice treated with saline or morphine for the last 8 days. Groups compared by an unpaired 
two-tailed Student’s t-test. N=6 for all groups. 
  
 
  
 
  
 
 
